Injectable Wrinkle Treatments (Botox & Dysport)

Injectable wrinkle treatments like Botox® and Dysport® are quick and safe procedures that will take years off your face with little to no side effects. There is little down time and lasting results with these treatments.  Their affordability also makes it a great place to start with cosmetic facial surgery. 

 Botox Cosmetic Logo
Dysport Logo  

Note: Both Botox® and Dysport are reversible if the patient does not enjoy the result. 


  • What is it? great way to reduce fine lines and wrinkles around the eyes and forehead. Also used to help TMJ/ Jaw clenching 
  • Downtime? None/minimal
  • Cost? $
  • Anesthesia: None
  • Who is it for: Any adults

Call West End Office Phone Number 804-270-5028 or click to schedule your consultation with Dr. Agnihotri.


Botox Cosmetic Logo
BOTOX® Cosmetic (onabotulinumtoxinA) Important Information

Indications
BOTOX® Cosmetic (onabotulinumtoxinA) is indicated in adult patients for the temporary improvement in the appearance of:
– moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity
– moderate to severe lateral canthal lines associated with orbicularis oculi activity
– moderate to severe forehead lines associated with frontalis activity
IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING
WARNING: DISTANT SPREAD OF TOXIN EFFECT
Postmarketing reports indicate that the effects of BOTOX® Cosmetic and all botulinum toxin
products may spread from the area of injection to produce symptoms consistent with botulinum
toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in
children treated for spasticity but symptoms can also occur in adults treated for spasticity and other
conditions, particularly in those patients who have an underlying condition that would predispose
them to these symptoms. In unapproved uses, including spasticity in children, and in approved
indications, cases of spread of effect have been reported at doses comparable to those used to
treat cervical dystonia and spasticity and at lower doses.
Important Safety Information (PDF)
Dysport Logo  
Dysport® (abobotulinumtoxinA) Important Information

Indication:
Dysport® (abobotulinumtoxinA) for Injection is an acetylcholine release inhibitor and a neuromuscular blocking agent indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with procerus and corrugator muscle activity in adult patients ˂65 years of age.

Distant Spread of Toxin Effect

Postmarketing reports indicate that the effects of Dysport and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have underlying conditions that would predispose them to these symptoms. In unapproved uses, including upper limb spasticity in children, and in approved indications, cases of spread of effect have been reported at doses comparable to or lower than the maximum recommended total dose.

Contraindications

Hypersensitivity to any botulinum toxin product or excipients Allergy to cow’s milk protein Infection at the proposed injection site(s)
Warnings and Precautions

The potency Units of Dysport are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of Dysport cannot be compared to or converted into units of any other botulinum toxin products.
Recommended dose and frequency of administration should not be exceeded.
Immediate medical attention may be required in cases of respiratory, speech or swallowing difficulties.
Concomitant neuromuscular disorder may exacerbate clinical effects of treatment.
Dysport contains human albumin. There is a risk for transmission of Creutzfeldt-Jakob disease (CJD) however, no cases of transmission of viral diseases or CJD have ever been identified for albumin.
Adverse Reaction

In clinical studies, the most frequently reported adverse events (≥2%) were nasopharyngitis, headache, injection site pain, injection site reaction, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, and blood present in urine.
Drug Interactions

Concomitant use of Dysport and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like agents), or muscle relaxants, should be observed closely because the effect of the botulinum toxin may be potentiated.
Anticholinergic drugs may potentiate systemic anticholinergic effects.
Excessive weakness may be exacerbated by administration of different botulinum neurotoxins and/or muscle relaxants during the course of treatment with Dysport.
Use in Specific Populations

Dysport is not recommended for use in children or pregnant women
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.


Call West End Office Phone Number 804-270-5028 or click to schedule your consultation with Dr. Agnihotri.